A rating of 77 puts Madrigal Pharmaceuticals Inc (MDGL) near the top of the Biotechnology industry according to InvestorsObserver. Madrigal Pharmaceuticals Inc's score of 77 means it scores higher than 77% of stocks in the industry. Madrigal Pharmaceuticals Inc also received an overall rating of 61, putting it above 61% of all stocks. Biotechnology is ranked 47 out of the 148 industries.
MDGL has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on MDGL!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 61 would rank higher than 61 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Madrigal Pharmaceuticals Inc Stock Today?
Madrigal Pharmaceuticals Inc (MDGL) stock is trading at $184.13 as of 11:41 AM on Monday, Nov 20, a rise of $7.47, or 4.23% from the previous closing price of $176.66. The stock has traded between $175.84 and $187.69 so far today. Volume today is less active than usual. So far 205,731 shares have traded compared to average volume of 463,504 shares.
Click Here to get the full Stock Report for Madrigal Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
